⚠ FOR RESEARCH USE ONLY
Sermorelin

CHEMICAL PROPERTIES

CAS NUMBER86168-78-7
MOLECULAR WEIGHT3357.93 g/mol
MOLECULAR FORMULAC₁₄₉H₂₄₆N₄₄O₄₂S

PHYSICAL PROPERTIES

APPEARANCEWhite lyophilized powder in sealed borosilicate glass vial.
SEQUENCETyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
Secretagogue Research

Sermorelin

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) comprising the first 29 amino acids of endogenous GHRH. Studied for its ability to stimulate pituitary GH secretion.

1
Free shipping on orders over $150
2-day delivery
LOT NUMBERLMO-DS-0626-SRM-003
REPORT NO.RPT-20021
HPLC PURITY98.50%

7× Independently Tested

HPLC PurityIndependent lab
IdentitySequence confirmed
Net ContentExact mg verified
SterilityContamination-free
EndotoxinsLAL tested
Heavy MetalsICP-MS screened
Batch ConsistencyLot-to-lot stability
7×
TESTED
⚠

RESEARCH USE ONLY

This compound is sold strictly for in vitro research and laboratory use. Not for human or animal consumption. Not a drug, food, or supplement. By purchasing you confirm you are a qualified researcher and will use this compound in compliance with all applicable laws. Must be 21 or older.

RESEARCH

Sermorelin: A Better Approach to Management of Adult-Onset Growth Hormone Insufficiency?
Walker RF. · Clinical Interventions in Aging · 2006
Reviews Sermorelin as a GHRH analogue alternative to recombinant human growth hormone therapy in age-related GH insufficiency, noting its physiological pulsatile stimulation mechanism preserves natural feedback regulation.
PMID 18046908
Pharmacokinetics of Growth Hormone-Releasing Hormone(1-29)-NH2 and Stimulation of Growth Hormone Secretion in Healthy Subjects
Bercu BB, et al. · Acta Paediatrica · 1993
Characterises dose-dependent GH release following intravenous and intranasal GHRH(1-29) administration in healthy adult men, with sustained GH elevation following repeated dosing.
PMID 8329825
Growth Hormone Secretagogues: History, Mechanism of Action, and Clinical Development
Ishida J, Saitoh M, Ebner N, et al. · JCSM Rapid Communications · 2020
Reviews Sermorelin as a 29-amino-acid GHRH(1-29) analogue, noting it stimulates pituitary GH release without significantly altering prolactin, cortisol, or thyroid hormone levels, supporting FDA approval for GH deficiency in 1997.

LAB RESULTS

LOT LMO-DS-0626-SRM-003 · CURRENT

Certificate of Analysis

PURITY
98.50%
CAS
86168-78-7
MW
3357.93 g/mol
APPEARANCE
White lyophilized powder in sealed borosilicate glass vial.
VERIFIED

Third-Party Report

TESTING LABIndependent Analytics LLC
TEST DATEJanuary 2025
METHODS USED
HPLCMSAAA
RESEARCH APPLICATIONS

What the literature covers.

  • ●GHRH(1-29) analogue studied for pituitary somatotroph stimulation
  • ●Investigated for pulsatile GH release and downstream IGF-1 elevation
  • ●Evaluated for age-related GH deficiency research protocols
  • ●Shorter half-life than CJC-1295 studied for more physiological GH pulse patterns

All compounds sold by Lumo are intended strictly for in vitro research and laboratory use only. These products are NOT intended for human consumption, medical, veterinary, or household use. By purchasing from Lumo, you acknowledge that you are a qualified researcher or institution and will use these products solely for research purposes in compliance with all applicable laws and regulations.

L-003

Stay current.

New lot releases, research updates, and product announcements.

Unsubscribe anytime. Research use communications only.

Research Use Only · Not for Human Consumption · For Laboratory Research Purposes Only

Your Cart

● All items for research use only. Not for human consumption.
●

Your cart is empty

Add compounds to get started